|
Volumn 50, Issue MAR., 2004, Pages 422-424
|
Adverse drug reactions in Canada: Bisphosphonates and ocular disorders;Effets indésirables des médicaments au Canada: Les bisphosphonates et les troubles oculaires
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
BECLOMETASONE;
BISPHOSPHONIC ACID DERIVATIVE;
BUDESONIDE;
CLODRONIC ACID;
CORTICOSTEROID;
ETIDRONIC ACID;
FLUTICASONE;
GLUCOCORTICOID;
PAMIDRONIC ACID;
RISEDRONIC ACID;
ZOLEDRONIC ACID;
ABDOMINAL PAIN;
ADRENAL INSUFFICIENCY;
ADRENAL SUPPRESSION;
ANOREXIA;
ASTHMA;
BODY WEIGHT DISORDER;
CANADA;
CONJUNCTIVITIS;
CONSCIOUSNESS DISORDER;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG EXPOSURE;
DRUG INDICATION;
DRUG MARKETING;
DRUG WITHDRAWAL;
EPISCLERITIS;
EYE DISEASE;
EYE INFLAMMATION;
EYE PAIN;
FATIGUE;
HEADACHE;
HUMAN;
HYPOGLYCEMIA;
NAUSEA;
NOTE;
OPHTHALMOLOGY;
PATIENT COMPLIANCE;
PATIENT REFERRAL;
PHOTOPHOBIA;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
SCLERITIS;
SEIZURE;
UVEITIS;
VISUAL IMPAIRMENT;
VOMITING;
ADRENAL INSUFFICIENCY;
ANDROSTADIENES;
BRONCHODILATOR AGENTS;
CANADA;
DIPHOSPHONATES;
EYE DISEASES;
HUMANS;
VISION DISORDERS;
|
EID: 1642352537
PISSN: 0008350X
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|